Silver Book Fact

Researchers have found how to manipulate embryonic stem cells to form dopamine-producing brain cells. This new source of cells could someday be used to replace cells lost to Parkinson’s.

Perrier, Anselme L., Viviane Tabar, Tiziano Barberi, Maria E. Rubio, Juan Bruses, Norbert Topf, Neil L. Harrison, and Lorenz Studer. Derivation of Midbrain Dopamine Neurons from Human Embryonic Stem Cells. Proceedings of the National Academy of Sciences. 2004; 101(34): 12543-8. http://www.pnas.org/cgi/content/short/101/34/12543

Reference

Title
Derivation of Midbrain Dopamine Neurons from Human Embryonic Stem Cells
Publication
Proceedings of the National Academy of Sciences
Publication Date
2004
Authors
Perrier, Anselme L., Viviane Tabar, Tiziano Barberi, Maria E. Rubio, Juan Bruses, Norbert Topf, Neil L. Harrison, and Lorenz Studer
Volume & Issue
Volume 101, Issue 34
Pages
12543-8
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Based on rates of admission in 1998, delaying admission of Alzheimer’s patients to nursing homes by 1 month could save as much as $1.12 billion a year.  
  • A large set of NIH clinical trials are assessing interventions (including dietary supplements–creatine and coenzyme Q10) that may slow the progression of Parkinson’s disease.  
  • More Effective Treatment of Alzheimer’s Disease Could Save Billions: Combined Medicare and Medicaid savings from effective treatment of Alzheimer’s diease  
  • Research shows that use of donepezil leads to a 4-fold increase in drug costs; however, it significantly lowers overall medical costs, reducing medical treatment and prescription drug costs by $3,891…  
  • New Medicines in Development for Parkinson’s Disease in 2018